These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 9752279)

  • 41. p19ARF prevents G1 cyclin-dependent kinase activation by interacting with MDM2 and activating p53 in mouse fibroblasts.
    Kurokawa K; Tanaka T; Kato J
    Oncogene; 1999 Apr; 18(17):2718-27. PubMed ID: 10348346
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53.
    Pomerantz J; Schreiber-Agus N; Liégeois NJ; Silverman A; Alland L; Chin L; Potes J; Chen K; Orlow I; Lee HW; Cordon-Cardo C; DePinho RA
    Cell; 1998 Mar; 92(6):713-23. PubMed ID: 9529248
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities.
    Ichimura K; Bolin MB; Goike HM; Schmidt EE; Moshref A; Collins VP
    Cancer Res; 2000 Jan; 60(2):417-24. PubMed ID: 10667596
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cooperativity of p19ARF, Mdm2, and p53 in murine tumorigenesis.
    Moore L; Venkatachalam S; Vogel H; Watt JC; Wu CL; Steinman H; Jones SN; Donehower LA
    Oncogene; 2003 Oct; 22(49):7831-7. PubMed ID: 14586409
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Alternative protein p19ARF: a genuine tumor suppressor gene].
    Larsen CJ
    Bull Cancer; 1998 Apr; 85(4):304-6. PubMed ID: 9752293
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mdm2: the ups and downs.
    Juven-Gershon T; Oren M
    Mol Med; 1999 Feb; 5(2):71-83. PubMed ID: 10203572
    [No Abstract]   [Full Text] [Related]  

  • 47. Mdm2: keeping p53 under control.
    Piette J; Neel H; Maréchal V
    Oncogene; 1997 Aug; 15(9):1001-10. PubMed ID: 9285554
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activation and activities of the p53 tumour suppressor protein.
    Bálint E E; Vousden KH
    Br J Cancer; 2001 Dec; 85(12):1813-23. PubMed ID: 11747320
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulation of p53 stability.
    Ashcroft M; Vousden KH
    Oncogene; 1999 Dec; 18(53):7637-43. PubMed ID: 10618703
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of the p53 pathway by Ras, the plot thickens.
    McMahon M; Woods D
    Biochim Biophys Acta; 2001; 1471(2):M63-71. PubMed ID: 11342185
    [No Abstract]   [Full Text] [Related]  

  • 51. [Tumorogenesis and mdm2 protein].
    Flores C; Sobrevia L
    Rev Med Chil; 2000 May; 128(5):539-46. PubMed ID: 11008360
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cell cycle regulatory functions of the human oncoprotein MDM2.
    Deb SP
    Mol Cancer Res; 2003 Dec; 1(14):1009-16. PubMed ID: 14707284
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MDM2 function.
    Lozano G; Montes de Oca Luna R
    Biochim Biophys Acta; 1998 Apr; 1377(2):M55-9. PubMed ID: 9606977
    [No Abstract]   [Full Text] [Related]  

  • 54. [When p19ARF finds a partner or new "dangerous liaisons"].
    Larsen CJ
    Bull Cancer; 1998 Jun; 85(6):523-6. PubMed ID: 9752279
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.